logo
Select company
Select metric
$ 14.75MNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
68
Sector
78
Industry
80
History
60
$ 1.42Close
$ 0.29 - $ 2.08 52-Week Range
Ticker Information

Ticker

LXRX

Company Name

LEXICON PHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

LEXICON PHARMACEUTICALS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

LXRX - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ 14.75M
3/31/2025$ -33.61M
12/31/2024$ 44.19M
9/30/2024$ 13.44M
6/30/2024$ -66.65M
3/31/2024$ 70.49M
12/31/2023$ -23.88M
9/30/2023$ 2.28M
6/30/2023$ 80.82M
3/31/2023$ -33.52M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • LEXICON PHARMACEUTICALS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ -117.95M.
  • Over the past 5 years, LEXICON PHARMACEUTICALS INC's average CF - Chg. Cash has been $ -6.72M.
  • The median CF - Chg. Cash for LEXICON PHARMACEUTICALS INC during this period was $ -7.72M
  • LEXICON PHARMACEUTICALS INC reached its highest CF - Chg. Cash over the past 5 years at $ 90.15M.
  • The lowest CF - Chg. Cash recorded by LEXICON PHARMACEUTICALS INC in the same timeframe $ -117.95M

LEXICON PHARMACEUTICALS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
NKTR : NEKTAR THERAPEUTICS $ 15.05MXOMA : XOMA ROYALTY CORP $ -71.44MCDXS : CODEXIS INC $ 8.15MGOSS : GOSSAMER BIO INC $ -60.57MSCPH : SCPHARMACEUTICALS INC $ 2.31MSAGE : SAGE THERAPEUTICS INC $ -33.8MADCT : ADC THERAPEUTICS SA $ -35.83MYMAB : Y-MABS THERAPEUTICS INC $ -15.51METON : ETON PHARMACEUTICALS INC $ 7.68MZVRA : ZEVRA THERAPEUTICS INC $ 8.45M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

LXRX - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -117.95M

Minimum

Sep 30, 2020

$ 90.15M

Maximum

Dec 31, 2020

$ -6.72M

Average

$ -7.72M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.18M with a standard deviation of $ 44.92M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.18M
median$ 115.89K
std$ 44.92M